Gamma Valerolactone Market Size(US$)

CAGR 2026-2032
2.8%
Market Size,2032
USD 731
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Gamma Valerolactone, commonly abbreviated as GVL, is a five-membered cyclic ester with the molecular formula C5H8O2 and CAS number 108-29-2. It is generally supplied as a colorless to pale-yellow liquid and is used in food flavors, fragrance formulations, industrial solvents, pharmaceutical and fine-chemical synthesis, polymer intermediates, lubricants, plasticizers and energy-related chemicals. GVL can be manufactured through the catalytic hydrogenation and cyclization of levulinic acid or levulinate esters using biomass-derived or petrochemical feedstocks. In 2025, global Gamma Valerolactone production reached approximately 26.5 K MT.
Gamma-valerolactone (GVL) is a renewable organic compound derived mainly from biomass sources such as lignocellulosic materials. It serves as a versatile green solvent, fuel additive, and intermediate in the production of chemicals, polymers, and pharmaceuticals. Its environmentally friendly profile, biodegradability, and relatively low toxicity make it attractive in applications where sustainable alternatives are sought to replace petroleum-based solvents and intermediates. GVL is also being explored as a platform molecule for producing biofuels and value-added chemicals, further enhancing its strategic importance in the shift toward a circular and bio-based economy.
The market for gamma-valerolactone is driven by the growing demand for green solvents in industrial processes, the need for sustainable fuel additives, and the rising interest in bio-based chemicals. Key end-use industries include chemicals, energy, pharmaceuticals, and agrochemicals, with research and development playing a significant role in expanding its commercial viability. However, challenges such as high production costs and limited large-scale manufacturing capacity currently restrict its widespread adoption. As advances in biomass conversion technologies mature and scale up, the market is expected to expand steadily, with strong opportunities in regions focusing on renewable energy and sustainable chemical production.
MARKET SEGMENTATION
REPORT SCOPE
The global Gamma Valerolactone market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Gamma Valerolactone sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Gamma Valerolactone manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Gamma Valerolactone product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gamma Valerolactone value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Gamma Valerolactone Product Scope
1.2 Gamma Valerolactone by Type
1.2.1 Global Gamma Valerolactone Sales by Type (2021, 2025 & 2032)
1.2.2 Food Grade
1.2.3 Industrial Grade
1.3 Gamma Valerolactone by Application
1.3.1 Global Gamma Valerolactone Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Food Flavors
1.3.3 Solvent
1.3.4 Monomer Intermediate
1.3.5 Others
1.4 Global Gamma Valerolactone Market Estimates and Forecasts (2021-2032)
1.4.1 Global Gamma Valerolactone Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Gamma Valerolactone Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Gamma Valerolactone Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Gamma Valerolactone Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Gamma Valerolactone Historical Market Scenario by Region (2021-2026)
2.2.1 Global Gamma Valerolactone Sales Market Share by Region (2021-2026)
2.2.2 Global Gamma Valerolactone Revenue Market Share by Region (2021-2026)
2.3 Global Gamma Valerolactone Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Gamma Valerolactone Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Gamma Valerolactone Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Gamma Valerolactone Market Size and Prospects (2021-2032)
2.4.2 Europe Gamma Valerolactone Market Size and Prospects (2021-2032)
2.4.3 China Gamma Valerolactone Market Size and Prospects (2021-2032)
2.4.4 Japan Gamma Valerolactone Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Gamma Valerolactone Historical Market Review by Type (2021-2026)
3.1.1 Global Gamma Valerolactone Sales by Type (2021-2026)
3.1.2 Global Gamma Valerolactone Revenue by Type (2021-2026)
3.1.3 Global Gamma Valerolactone Average Price by Type (2021-2026)
3.2 Global Gamma Valerolactone Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Gamma Valerolactone Sales Forecast by Type (2027-2032)
3.2.2 Global Gamma Valerolactone Revenue Forecast by Type (2027-2032)
3.2.3 Global Gamma Valerolactone Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Gamma Valerolactone
4 Global Market Size by Application
4.1 Global Gamma Valerolactone Historical Market Review by Application (2021-2026)
4.1.1 Global Gamma Valerolactone Sales by Application (2021-2026)
4.1.2 Global Gamma Valerolactone Revenue by Application (2021-2026)
4.1.3 Global Gamma Valerolactone Average Price by Application (2021-2026)
4.2 Global Gamma Valerolactone Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Gamma Valerolactone Sales Forecast by Application (2027-2032)
4.2.2 Global Gamma Valerolactone Revenue Forecast by Application (2027-2032)
4.2.3 Global Gamma Valerolactone Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Gamma Valerolactone Applications
5 Competition Landscape by Players
5.1 Global Gamma Valerolactone Sales by Player (2021-2026)
5.2 Global Top Gamma Valerolactone Players by Revenue (2021-2026)
5.3 Global Gamma Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Gamma Valerolactone revenue as of 2025
5.4 Global Gamma Valerolactone Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Gamma Valerolactone, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Gamma Valerolactone, Product Type & Application
5.7 Global Key Manufacturers of Gamma Valerolactone, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Gamma Valerolactone Sales by Company
6.1.1.1 North America Gamma Valerolactone Sales by Company (2021-2026)
6.1.1.2 North America Gamma Valerolactone Revenue by Company (2021-2026)
6.1.2 North America Gamma Valerolactone Sales Breakdown by Type (2021-2026)
6.1.3 North America Gamma Valerolactone Sales Breakdown by Application (2021-2026)
6.1.4 North America Gamma Valerolactone Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Gamma Valerolactone Sales by Company
6.2.1.1 Europe Gamma Valerolactone Sales by Company (2021-2026)
6.2.1.2 Europe Gamma Valerolactone Revenue by Company (2021-2026)
6.2.2 Europe Gamma Valerolactone Sales Breakdown by Type (2021-2026)
6.2.3 Europe Gamma Valerolactone Sales Breakdown by Application (2021-2026)
6.2.4 Europe Gamma Valerolactone Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Gamma Valerolactone Sales by Company
6.3.1.1 China Gamma Valerolactone Sales by Company (2021-2026)
6.3.1.2 China Gamma Valerolactone Revenue by Company (2021-2026)
6.3.2 China Gamma Valerolactone Sales Breakdown by Type (2021-2026)
6.3.3 China Gamma Valerolactone Sales Breakdown by Application (2021-2026)
6.3.4 China Gamma Valerolactone Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Gamma Valerolactone Sales by Company
6.4.1.1 Japan Gamma Valerolactone Sales by Company (2021-2026)
6.4.1.2 Japan Gamma Valerolactone Revenue by Company (2021-2026)
6.4.2 Japan Gamma Valerolactone Sales Breakdown by Type (2021-2026)
6.4.3 Japan Gamma Valerolactone Sales Breakdown by Application (2021-2026)
6.4.4 Japan Gamma Valerolactone Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Soda Aromatic
7.1.1 Soda Aromatic Company Information
7.1.2 Soda Aromatic Business Overview
7.1.3 Soda Aromatic Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Soda Aromatic Gamma Valerolactone Products Offered
7.1.5 Soda Aromatic Recent Development
7.2 Anhui Hyea Aromas
7.2.1 Anhui Hyea Aromas Company Information
7.2.2 Anhui Hyea Aromas Business Overview
7.2.3 Anhui Hyea Aromas Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Anhui Hyea Aromas Gamma Valerolactone Products Offered
7.2.5 Anhui Hyea Aromas Recent Development
7.3 LangFang Hawk T&D
7.3.1 LangFang Hawk T&D Company Information
7.3.2 LangFang Hawk T&D Business Overview
7.3.3 LangFang Hawk T&D Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.3.4 LangFang Hawk T&D Gamma Valerolactone Products Offered
7.3.5 LangFang Hawk T&D Recent Development
7.4 Chongqing Zoteq Aromachemical
7.4.1 Chongqing Zoteq Aromachemical Company Information
7.4.2 Chongqing Zoteq Aromachemical Business Overview
7.4.3 Chongqing Zoteq Aromachemical Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Chongqing Zoteq Aromachemical Gamma Valerolactone Products Offered
7.4.5 Chongqing Zoteq Aromachemical Recent Development
7.5 Jiangsu Qingquan Chemical
7.5.1 Jiangsu Qingquan Chemical Company Information
7.5.2 Jiangsu Qingquan Chemical Business Overview
7.5.3 Jiangsu Qingquan Chemical Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Jiangsu Qingquan Chemical Gamma Valerolactone Products Offered
7.5.5 Jiangsu Qingquan Chemical Recent Development
7.6 Juye Zhongyue Aroma
7.6.1 Juye Zhongyue Aroma Company Information
7.6.2 Juye Zhongyue Aroma Business Overview
7.6.3 Juye Zhongyue Aroma Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Juye Zhongyue Aroma Gamma Valerolactone Products Offered
7.6.5 Juye Zhongyue Aroma Recent Development
7.7 Kunshan Baihua Biotechnology
7.7.1 Kunshan Baihua Biotechnology Company Information
7.7.2 Kunshan Baihua Biotechnology Business Overview
7.7.3 Kunshan Baihua Biotechnology Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Kunshan Baihua Biotechnology Gamma Valerolactone Products Offered
7.7.5 Kunshan Baihua Biotechnology Recent Development
7.8 Inoue Perfumery MFG
7.8.1 Inoue Perfumery MFG Company Information
7.8.2 Inoue Perfumery MFG Business Overview
7.8.3 Inoue Perfumery MFG Gamma Valerolactone Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Inoue Perfumery MFG Gamma Valerolactone Products Offered
7.8.5 Inoue Perfumery MFG Recent Development
8 Gamma Valerolactone Manufacturing Cost Analysis
8.1 Gamma Valerolactone Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Gamma Valerolactone
8.4 Gamma Valerolactone Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Gamma Valerolactone Distributors List
9.3 Gamma Valerolactone Customers
10 Gamma Valerolactone Market Dynamics
10.1 Gamma Valerolactone Industry Trends
10.2 Gamma Valerolactone Market Drivers
10.3 Gamma Valerolactone Market Challenges
10.4 Gamma Valerolactone Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-12
Pages: 136
USD 4900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 135
USD 3950.00
(Single User License)
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-07
Pages: 141
USD 4900.00
(Single User License)
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published: 2024-04-17
Pages: 151
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-12
Pages: 136
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 135
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-07
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report